Procalcitonin Increase Identifies Critically Ill Patients at High Risk of Mortality
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00144638|
Recruitment Status : Completed
First Posted : September 5, 2005
Last Update Posted : September 5, 2005
Procalcitonin, a marker of infection has often been compared to clinical pictures as for instance "clinical sepsis". This has given som problems in the interpretation of these studies, because of the lack of good Gold Standards for "clinical sepsis. We have decided to investigate the development from day to day of Procalcitonin in the blood of intensive care patients, compared to the mortality.
Hypothesis: Procalcitonin increase after reaching a certain level predicts mortality in the Intensive Care Unit.
|Condition or disease|
|Sepsis - to Reduce Mortality in the Intensive Care Unit|
Show Detailed Description
|Study Type :||Observational|
|Enrollment :||450 participants|
|Observational Model:||Defined Population|
|Observational Model:||Natural History|
|Official Title:||Procalcitonin Increase Identifies Critically Ill Patients at High Risk of Mortality|
|Study Start Date :||January 2002|
|Study Completion Date :||January 2003|
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00144638
|Dept. 4131, Rigshospitalet, Cph University Hosp., DK|
|Copenhagen, Denmark, DK-2100|
|Principal Investigator:||Lars Heslet, MD, MD.Sc.||Dept. 4131, Rigshospitalet, Blegdamsvej 9, DK-2100|